Short description
Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.
Description
Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Epalinges, Vaud, Switzerland, Europe
Founded on
January 1, 2002
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccessforu, No Way
Sign in for full access
Founders
Christophe Bonny, Peter Harboe Schmidt